Undissociated gelatine tannate and xyloglucan prevent gut leakiness and mucosal inflammation induced by LPS: insights in the mechanism of action.

H. Eutamene. P1449. UEG journal. October 2016. Vol 4. Suppl. 1 Pag A651 Introduction: Gelatine tannate (GT) and xylogucan (XG) are commercially available in several countries for the oral treatment of diarrhea in children and adults. However, the mechanism of action remains poorly understood. Aims & Methods: Therefore, we aimed to [...]

Read More

Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for ‘gut barrier protectors’ in IBD?

Franco Scaldaferri Loris Riccardo Lopetuso1, Valentina Petito, et al. United European Gastroenterology Journal 2014, Vol. 2(2) 113–122 Background: Gelatin tannate, a gelatin powder containing tannic acids, is commonly employed as an intestinal astringent. Neither information nor animal model exist to confirm its efficacy or unravel mechanisms of action. Objective: To [...]

Read More

ESPGHAN 2025

Helsinki, Finland, 14-17 May 2025 Noventure will attend the 57th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), taking place in Helsinki, Finland, from May 14th to 17th, 2024 Arrange a meeting with us to learn more about our products and license availability in the [...]

Read More

ESPGHAN 2023

Vienna, Austria, 17-20 May Noventure will attend the 55th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), taking place in Vienna & Online, from May 17th to 23rd, 2023 Arrange a meeting with us to learn more about our products and license availability in the [...]

Read More